References
- Drenth JP, Denecker NE, Prieur AM, van der Meer JW. Hyper-immunoglobulin D syndrome. Presse Med. 1995;24:1211–3.
- Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.
- Sogo T, Fujisawa T, Inui A, Komatsu H, Etani Y, Tajiri H, et al. Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis. Hepatol Res. 2006;34:187–92.
- Houten SM, Wanders RJA, Waterham HR. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta. 2000;1529:19–32.
- Simon A, Kremer HPH, Wevers RA, Scheffer H, de Jong JG, van der Meer JWM, et al. Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology. 2004;62:994–7.
- Kage M. Pathology of autoimmune liver diseases in children. Hepatol Res. 2007;37:5502–8.
- Manns MP, Czaja AJ, Gorham JD, Krawitt El, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–213.
- Topaloglu R, Ayaz NA, Waterham HR, Yuce A, Gumruk F, Sanal 0. Hyperimmunoglobulinemia D and periodic fever syn-drome; treatment with etanercept and follow-up. Clin Rheumatol. 2008;27:1317–20.
- Hinson DD, Rogers ZR, Hoffmann GF, Schachtele M, Fingerhut R, Kohlschtter A, et al. Hematological abnormalities and chole-static liver disease in two patients with mevalonate kinase defi-ciency. Am J Med Genet. 1998;78:408–12.
- Komatsu M, Takahashi T, Uemura N, Takada G. Familial Med-iterranean fever medicated with an herbal medicine in Japan. Pediatr Int. 2004;46:81–4.
- Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.
- Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S, et al. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmu-noglobulinemia D with periodic fever syndrome: a low-pene-trance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum. 2004;50:1951–8.
- Van der Hi1st JC, Bodar RI, Barron KS, Frenkel J, Drenth JP, van der Meer JW, International HIDS Study Group, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87: 301–10.